{"transactions":[{"id":2274605,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T17:59:33.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":307,"price":15.9665,"value":4901.7155,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.96 to $15.97 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1822790,"source":{"system":"sec-edgar","filing":"0001567619-22-010101","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000156761922010101/doc1.xml","form_type":"4"}},{"id":2274604,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T17:59:33.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":18415,"price":15.2157,"value":280197.1155,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.93 to $15.891 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1823097,"source":{"system":"sec-edgar","filing":"0001567619-22-010101","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000156761922010101/doc1.xml","form_type":"4"}},{"id":2274603,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T17:59:33.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":18966,"price":14.2037,"value":269387.3742,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.93 to $14.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1841512,"source":{"system":"sec-edgar","filing":"0001567619-22-010101","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000156761922010101/doc1.xml","form_type":"4"}},{"id":2274602,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T17:59:33.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":37312,"price":13.2984,"value":496189.9008,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.93 to $13.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1860478,"source":{"system":"sec-edgar","filing":"0001567619-22-010101","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000156761922010101/doc1.xml","form_type":"4"}},{"id":2401258,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T16:25:52.000Z","date":"2021-09-07","kind":"grant","acquired":true,"shares":408816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of shares held in trusts for which his spouse is a co-trustee."}],"balance_after":408816,"source":{"system":"sec-edgar","filing":"0001567619-22-003539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000156761922003539/doc1.xml","form_type":"5"}},{"id":2401257,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T16:25:52.000Z","date":"2021-09-07","kind":"gift","acquired":false,"shares":408816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of shares held in trusts for which his spouse is a co-trustee."}],"balance_after":1897790,"source":{"system":"sec-edgar","filing":"0001567619-22-003539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000156761922003539/doc1.xml","form_type":"5"}},{"id":2735682,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:13:56.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":427875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering.  The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":427875},"source":{"system":"sec-edgar","filing":"0000899243-21-017470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000089924321017470/doc4.xml","form_type":"4"}},{"id":2735681,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:13:56.000Z","date":"2021-04-27","kind":"other","acquired":true,"shares":9906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering.  The shares had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."}],"balance_after":9906,"derivative":{"underlying":"Common Stock","underlying_shares":9906},"source":{"system":"sec-edgar","filing":"0000899243-21-017470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000089924321017470/doc4.xml","form_type":"4"}},{"id":2735680,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T21:13:56.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":401250,"price":17,"value":6821250.0,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters."}],"balance_after":2306606,"source":{"system":"sec-edgar","filing":"0000899243-21-017470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000089924321017470/doc4.xml","form_type":"4"}},{"id":2735679,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":127396,"kind":"person","name":"TREACE JOHN R","position":1,"cik":"0001185249","reported_name":"TREACE JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T21:13:56.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":427875,"ownership":{"direct":false,"nature":"John R. Treace and Ginger D. Treace JTTEN"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering.  The shares had no expiration date."}],"balance_after":2707856,"source":{"system":"sec-edgar","filing":"0000899243-21-017470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185249/000089924321017470/doc4.xml","form_type":"4"}}]}